Amgen: all 1,085 studies

Page 4 of 11. Open to participants first (51), then studies with results posted, then the rest; newest registration first within each.

• A Study of Oprozomib, Pomalidomide, and Dexamethasone in Adults With Primary Refractory or Relapsed and Refractory Multiple MyelomaTerminatedNCT01999335Phase 1Results posted
• TRANSFORM - Observational Cohort Study of Darbepoetin Alfa Use in European Union (EU) Hemodialysis Patients Switched From PEG Epoetin BetaCompletedNCT01997892Results posted
• Efficacy, Safety and Tolerability of Romosozumab in the Treatment of Japanese Women With Postmenopausal OsteoporosisCompletedNCT01992159Phase 2Results posted
• Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) In Japanese Patients With Moderate-To-Severe Plaque-Type PsoriasisCompletedNCT01988103Phase 2Results posted
• Phase 1b/2 Study of Carfilzomib, Carboplatin, and Etoposide in Patients With Previously Untreated Extensive Stage Small-cell Lung CancerCompletedNCT01987232Phase 1/2Results posted
• Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects-3CompletedNCT01984424Phase 3Results posted
• A Multicenter, Open-label, Phase 1b Study of Carfilzomib, Cyclophosphamide and Dexamethasone in Newly Diagnosed Multiple Myeloma SubjectsCompletedNCT01980589Phase 1Results posted
• Study to Compare Efficacy and Safety of ABP 501 and Adalimumab (HUMIRA®) in Adults With Moderate to Severe Plaque PsoriasisCompletedNCT01970488Phase 3Results posted
• Efficacy and Safety Study of ABP 501 Compared to Adalimumab in Subjects With Moderate to Severe Rheumatoid ArthritisCompletedNCT01970475Phase 3Results posted
• Efficacy and Safety Study of ABP 215 Compared With Bevacizumab in Patients With Advanced Non-Small Cell Lung CancerCompletedNCT01966003Phase 3Results posted
• Study of Low-Density Lipoprotein Cholesterol (LDL-C) Reduction Using Evolocumab (AMG 145) in Japanese Patients With Advanced Cardiovascular RiskCompletedNCT01953328Phase 3Results posted
• Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Migraine PreventionCompletedNCT01952574Phase 2Results posted
• Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung CancerCompletedNCT01951586Phase 2Results posted
• Study of the Pharmacokinetics and Safety of Carfilzomib in Patients With Advanced Malignancies and Hepatic ImpairmentCompletedNCT01949545Phase 1Results posted
• Study of the Pharmacokinetics and Safety of Carfilzomib in Patients With Multiple Myeloma and Renal DiseaseCompletedNCT01949532Phase 1Results posted
• Observational Study That Will Collect Information on Patients With Urea Cycle Disorders (UCDs)TerminatedNCT01948427Results posted
• Study to Assess the Impact on Calcium Levels When Hemodialysis Patients With Secondary Hyperparathyroidism (SHPT) Switch From Cinacalcet to EtelcalcetideCompletedNCT01932970Phase 3Results posted
• Evaluating Etanercept Use in Patients With Moderate to Severe Rheumatoid Arthritis Who Have Lost Response to AdalimumabTerminatedNCT01927757Phase 4Results posted
• Safety and Efficacy Study of Apremilast to Treat Psoriatic ArthritisCompletedNCT01925768Phase 3Results posted
• Study of Efficacy and Safety of Brodalumab Compared With Placebo in Adults With Inadequately Controlled Asthma With High Bronchodilator ReversibilityTerminatedNCT01902290Phase 2Results posted
• Study to Evaluate the Ability of Subjects With Rheumatoid Arthritis or Psoriatic Arthritis to Effectively Use a Reusable Autoinjector to Self-inject EtanerceptCompletedNCT01901185Phase 3Results posted
• Efficacy and Safety Study of ABP 980 Compared With Trastuzumab in Women With HER2-positive Early Breast CancerCompletedNCT01901146Phase 3Results posted
• Head-to-Head Study of Etelcalcetide (AMG 416) and CinacalcetCompletedNCT01896232Phase 3Results posted
• Study of South African Dialysis PatientsTerminatedNCT01890577Results posted
• Study of Erenumab (AMG 334) in Women With Hot FlashesCompletedNCT01890109Phase 1Results posted
• Oprozomib and Dexamethasone,in Combination With Lenalidomide or Oral Cyclophosphamide to Treat Newly Diagnosed Multiple MyelomaTerminatedNCT01881789Phase 1/2Results posted
• Study to Assess in Home Use of Evolocumab (AMG 145) Administration Using Either an Automated Mini-doser or a Prefilled Autoinjector/PenCompletedNCT01879319Phase 3Results posted
• Preference Between Two Autoinjectors in Patients With Rheumatoid Arthritis and Plaque Psoriasis Treated With EtanerceptCompletedNCT01875991Phase 4Results posted
• Study to Evaluate the Concentration of Denosumab in Seminal Fluid in Healthy Men After a Single Subcutaneous DoseCompletedNCT01869686Phase 1Results posted
• Teprotumumab (RV 001) Treatment in Patients With Active Thyroid Eye DiseaseCompletedNCT01868997Phase 2Results posted
• Open-label Extension Study of Evolocumab (AMG 145) in Adults With Hyperlipidemia and Mixed DyslipidemiaCompletedNCT01854918Phase 3Results posted
• Study to Assess In-home Use of Evolocumab (AMG 145) Using a Prefilled Syringe or a Prefilled Autoinjector/PenCompletedNCT01849497Phase 3Results posted
• Study of Romosozumab (AMG 785) Administered to Healthy Participants and Patients With Stage 4 Renal Impairment or Stage 5 Renal Impairment Requiring HemodialysisCompletedNCT01833754Phase 1Results posted
• Phase 1b/2, Multicenter, Open-label Study of Oprozomib and Dexamethasone in Patients With Relapsed and/or Refractory Multiple MyelomaTerminatedNCT01832727Phase 1/2Results posted
• A Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Romosozumab (AMG 785)CompletedNCT01825785Phase 1Results posted
• Denosumab for Prolonging Bone Metastasis-Free Survival in Men With Hormone-Refractory Prostate CancerCompletedNCT01824342Phase 3Results posted
• Phase 3 Study of Carfilzomib, Melphalan, Prednisone vs Bortezomib, Melphalan, Prednisone in Newly Diagnosed Multiple MyelomaCompletedNCT01818752Phase 3Results posted
• Study Investigating How Physicians Assess the Risk of Patients Developing Febrile Neutropenia During Chemotherapy.CompletedNCT01813721Results posted
• GLobal Assessment of Plaque reGression With a PCSK9 antibOdy as Measured by intraVascular UltrasoundCompletedNCT01813422Phase 3Results posted
• An Open-label Study to Evaluate the Effect of Treatment With Romosozumab or Teriparatide in Postmenopausal WomenCompletedNCT01796301Phase 3Results posted
• Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on HemodialysisCompletedNCT01788046Phase 3Results posted
• Extension Study of Etelcalcetide in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on HemodialysisCompletedNCT01785875Phase 3Results posted
• Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease on HemodialysisCompletedNCT01785849Phase 3Results posted
• Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated RiskCompletedNCT01764633Phase 3Results posted
• Reduction of LDL-C With PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder Study-2CompletedNCT01763918Phase 3Results posted
• Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects -2CompletedNCT01763905Phase 3Results posted
• LDL-C Assessment With PCSK9 Monoclonal Antibody Inhibition Combined With Statin Therapy-2CompletedNCT01763866Phase 3Results posted
• Monoclonal Antibody Against PCSK9 to Reduce Elevated LDL-C in Subjects Currently Not Receiving Drug Therapy for Easing Lipid Levels-2CompletedNCT01763827Phase 3Results posted
• Effect of Patient Education on Reported Bone Pain in Breast Cancer Patients Receiving Chemotherapy and PegfilgrastimCompletedNCT01752907Phase 2Results posted
• Safety/Effectiveness Study of Cysteamine Bitartrate Delayed-release Capsules (RP103) in Cysteamine Treatment Naive Patients With CystinosisCompletedNCT01744782Phase 3Results posted
• Clinical Study With Blinatumomab in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)CompletedNCT01741792Phase 2Results posted
• Ipilimumab With or Without Talimogene Laherparepvec in Unresected MelanomaCompletedNCT01740297Phase 1/2Results posted
• Evaluation of the Conversion From Peginesatide to Epoetin Alfa in Patients Receiving HemodialysisTerminatedNCT01737879Phase 4Results posted
• Open-Label, Safety and Superior Effectiveness Study of Cysteamine Bitartrate Delayed-Release Capsules (RP103) in CystinosisCompletedNCT01733316Phase 3Results posted
• Observational Study of Vectibix With Chemotherapy for Metastatic Colorectal Cancer PatientsCompletedNCT01732783Results posted
• Safety and Efficacy Study to Evaluate Denosumab Compared With Zoledronic Acid in Postmenopausal Women With OsteoporosisCompletedNCT01732770Phase 4Results posted
• Ascending Multiple-Doses of Erenumab (AMG 334) in Healthy Adults and in Migraine PatientsCompletedNCT01723514Phase 1Results posted
• Study to Evaluate the Prospective Payment SystemCompletedNCT01717989Results posted
• NOLAN: Naproxen or Loratadine and NeulastaCompletedNCT01712009Phase 2Results posted
• Abrilumab (AMG 181) in Adults With Moderate to Severe Crohn's DiseaseCompletedNCT01696396Phase 2Results posted
• Abrilumab (AMG 181) in Adults With Moderate to Severe Ulcerative ColitisCompletedNCT01694485Phase 2Results posted
• Phase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque PsoriasisCompletedNCT01690299Phase 3Results posted
• Ascending Single Doses of Erenumab (AMG 334) in Healthy Adults and Migraine PatientsCompletedNCT01688739Phase 1Results posted
• A Study of Weekly Carfilzomib in Combination With Dexamethasone for Progressive Multiple MyelomaCompletedNCT01677858Phase 1/2Results posted
• Observational Study of Denosumab (Prolia®) in Postmenopausal Women With OsteoporosisCompletedNCT01668589Results posted
• Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney DiseaseCompletedNCT01652872Phase 3Results posted
• A Study to Evaluate Tolerability and Efficacy of Evolocumab (AMG 145) in Japanese SubjectsCompletedNCT01652703Phase 2Results posted
• Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Denosumab (Prolia®) in Routine Clinical PracticeCompletedNCT01652690Results posted
• Effects of Age and Sex on the Pharmacokinetics of Apremilast in Healthy AdultsCompletedNCT01634191Phase 1Results posted
• Effect of Food on the Pharmacokinetics of Apremilast (CC-10004) in Healthy AdultsCompletedNCT01634178Phase 1Results posted
• Study to Determine the Efficacy and Safety of Romosozumab in the Treatment of Postmenopausal Women With OsteoporosisCompletedNCT01631214Phase 3Results posted
• Trial Assessing Long Term USe of PCSK9 Inhibition in Subjects With Genetic LDL DisordersCompletedNCT01624142Phase 2/3Results posted
• Transition From Alendronate to Romosozumab (AMG 785)CompletedNCT01588509Phase 1Results posted
• Trial Evaluating PCSK9 Antibody in Subjects With LDL Receptor AbnormalitiesCompletedNCT01588496Phase 2/3Results posted
• Study of Apremilast to Treat Subjects With Active Ankylosing SpondylitisCompletedNCT01583374Phase 3Results posted
• Efficacy and Safety of Denosumab Compared With Risedronate in Individuals Taking GlucocorticoidsCompletedNCT01575873Phase 3Results posted
• Efficacy and Safety of Romosozumab Treatment in Postmenopausal Women With OsteoporosisCompletedNCT01575834Phase 3Results posted
• Phase 3 Study With Carfilzomib and Dexamethasone Versus Bortezomib and Dexamethasone for Relapsed Multiple Myeloma PatientsCompletedNCT01568866Phase 3Results posted
• Open-label Safety and Pharmacokinetic Study of DUEXIS® (Ibuprofen and Famotidine) Tablets in Juvenile Idiopathic ArthritisCompletedNCT01563185Phase 4Results posted
• A Drug-Drug Interaction Study to Evaluate the Effect of Rifampin on the Pharmacokinetics of ApremilastCompletedNCT01561963Phase 1Results posted
• A Safety Study of VIMOVO in Adolescents With Juvenile Idiopathic Arthritis (JIA)CompletedNCT01544114Phase 4Results posted
• Etanercept Treatment in Patients With Moderate to Severe Plaque Psoriasis Who Lost Response to AdalimumabTerminatedNCT01543204Phase 4Results posted
• Durable Effect of PCSK9 Antibody CompARed wiTh placEbo StudyCompletedNCT01516879Phase 3Results posted
• Clinical Study With Blinatumomab in Pediatric and Adolescent Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic LeukemiaCompletedNCT01471782Phase 1/2Results posted
• Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)CompletedNCT01466179Phase 2Results posted
• Observational Study of the Use of Pegloticase (KRYSTEXXA®) in Refractory Chronic GoutCompletedNCT01466166Results posted
• Multiple Dose Study to Evaluate the Safety of Multiple Doses of Denosumab 120 mg in Adults With Severe Chronic Kidney Disease (CKD) and CKD on DialysisCompletedNCT01464931Phase 1Results posted
• Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced AnaemiaCompletedNCT01444456Results posted
• Safety and Efficacy Study of Romiplostim to Treat Immune Thrombocytopenia (ITP) in Pediatric PatientsCompletedNCT01444417Phase 3Results posted
• Open Label Study of Long Term Evaluation Against LDL-C TrialCompletedNCT01439880Phase 2Results posted
• Safety & Tolerability of Cinacalcet in Pediatric Patients With Chronic Kidney Disease and Secondary HyperparathyroidismTerminatedNCT01439867Phase 2Results posted
• Open-Label Access Protocol of Denosumab for Subjects With Advanced CancerCompletedNCT01419717Phase 3Results posted
• Comparison of Survival Benefit of Panitumumab With Supportive Care to Best Supportive Care Alone in Patients With Metastatic Colorectal CancerCompletedNCT01412957Phase 3Results posted
• Double-blind, Multiple Dose Study of Tezepelumab (AMG 157) in Adults With Mild Atopic AsthmaCompletedNCT01405963Phase 1Results posted
• LAPLACE-TIMI 57: Low-density Lipoprotein Cholesterol (LDL-C) Assessment With PCSK9 monoclonaL Antibody Inhibition Combined With Statin thErapyCompletedNCT01380730Phase 2Results posted
• Monoclonal Antibody Against PCSK9 to Reduce Elevated Low-density Lipoprotein Cholesterol (LDL-C) in Adults Currently Not Receiving Drug Therapy for Easing Lipid LevelsCompletedNCT01375777Phase 2Results posted
• Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant SubjectsCompletedNCT01375764Phase 2Results posted
• Reduction of Low-Density Lipoprotein Cholesterol (LDL-C) With PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder StudyCompletedNCT01375751Phase 2Results posted
• An Extended Use Study of Safety and Efficacy of Talimogene Laherparepvec in MelanomaCompletedNCT01368276Phase 3Results posted
• A Study to Evaluate the Safety and Efficacy of CCX168 in Subjects With ANCA-Associated VasculitisCompletedNCT01363388Phase 2Results posted

← Amgen overview and focus areas